Device Foam Dressings

Allevyn Gentle Border 10 X 10cm Ctn 10

Payments companies reported to CMS as associated with Allevyn Gentle Border 10 X 10cm Ctn 10. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$184Kassociated payments (2023-2025)
156clinicians with associated payments
1company reporting

By year

2023 $21K
2024 $106K
2025 $57K

Payments reported as associated with Allevyn Gentle Border 10 X 10cm Ctn 10, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Nurse Practitioner $25K
Dermatology $24K
Foot & Ankle Surgery $16K
Physician Assistant $15K
Vascular Surgery $15K
Family $13K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Allevyn Gentle Border 10 X 10cm Ctn 10

These are the largest totals companies reported as associated with Allevyn Gentle Border 10 X 10cm Ctn 10. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Robert Kirsner Miami, FL Dermatology $24,060.47
Catherine Milne Plymouth, CT Nurse Practitioner $18,998.84
David Zabel Augusta, GA Plastic Surgery $8,200.00
Ravi Bashyal Skokie, IL Orthopaedic Surgery $6,789.14
Reginald Abraham Fountain Valley, CA Thoracic Surgery (Cardiothoracic Vascular Surgery) $6,600.00
Lee Ruotsi Holland, MI Undersea and Hyperbaric Medicine (Preventive Medicine) $6,380.00
Lee Goldstein Stratford, CT Vascular Surgery $6,189.14
Vineet Mehan Falls Church, VA Plastic Surgery $1,956.97
John Lantis New York, NY Vascular Surgery $1,589.14
Razvan Pavelescu New York, NY Foot & Ankle Surgery $1,589.14

Prescribed Allevyn Gentle Border 10 X 10cm Ctn 10?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.